Cancer Conferences | Euro Cancer 2024 | December 12-13, 2024

Theme: {CME Credits available} Inspiring Progress: Innovations in Cancer Research

Euro Cancer 2024

Tentative Program

Renowned Speakers

Bashar Attar
Rush University Medical Center
USA

Kamal D. Mehta
The Ohio State University,
USA

Pegah Varamini
Breast Cancer Targeting & Drug Delivery Laboratory
Australia

Jianhua-Luo
University of Pittsburgh
USA

Shireen Samargandy
King Abdulaziz University
Saudi Arabia

Kiven Erique Lukong
University of Saskatchewan
Canada

Octavian Bucur
Viron Therapeutics
USA

Salwa Ahmed Elgebaly
Nour Heart Institute
USA

Rizwana Popatia
Weill Cornell Medical College,
USA

Emmanuelle Charafe-Jauffret
University of Mediterranee
France

Marco Bernini
Careggi University Hospital,
Italy

Mohammad F. Bayan
Philadelphia University,
Jordan

Debdulal Roy
Swansea University,
UK

Yifan Li
shanxi cancer hospital,
China

Hilary Whyte
University of Toronto,
Canada

Joao Paulo Martins do Carmo
State University of Goias,
Brazil

Dana Haddad
HealthBay Polyclinic,
UAE

Euro Cancer 2024

On behalf of Scientific Organizing Committee we are overwhelmed to welcome all the participants to attend 46^th Euro-Global Summit on Cancer Therapy & Radiation Oncology is scheduled for December 12-13, 2024 in Rome, Italy. Euro Cancer 2024 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions. Euro Cancer 2024 is a two day event consisting of a lettered scientific program, laudable talks by the top notch of the global scientific community, that brings together active researchers, intellectuals, academicians, students, contributors and industrialists to exchange ideas communicate and discuss research findings on new advancements in all kinds of available cancer therapies worldwide innovative research products which can be exhibited for further development in Oncology. This Cancer Congress is going to be the largest and most promising international conference that specifically focuses on the Radiation therapy by bringing all Renowned Radiation Oncologists under one roof. This is a two days multidisciplinary meeting covering all aspects of Cancer Therapies and Radiation Oncology, including clinical service delivery, management, informatics and research.

Importance & Scope

Euro Cancer 2024 will be the best platform for all the oncologists, hematologists, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an attempt to understand the primary biological approach which is enhanced to increase potency, precision, survivability and quality of life.

The Euro Cancer 2024 is the premier event that brings together International experts, Training Institutes, Pharmacy Industries, Manufacturing, Business Entrepreneurs, Medical Devices Companies Medical Colleges, Researchers, Physicians, Academicians, Students, Academic scientists, Post Docs, Industry professionals, Diagnostic laboratory professionals across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists to reduce the to reduce the global burden of cancer.

Euro Cancer 2024 is an extraordinary event designed for International medical health professionals and oncologists to facilitate the dissemination and application of new research findings related to Cancer. The conference invites participants from all leading universities, clinical research institutions and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques.

Young Researchers Benefits

Our conferences provide best Platform for your research through oral presentations.
Share the ideas with both eminent researchers and mentors.
Young Scientist Award reorganization certificate and memento to the winners
Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development
Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Track 1: Cancer Therapy

Cancer therapy encompasses a range of treatments aimed at eradicating or controlling cancer cells. Common approaches include surgery to remove tumors, radiation therapy to target and destroy cancer cells with high-energy rays, and chemotherapy to kill cancer cells using drugs. Targeted therapies and immunotherapies work by focusing on specific molecules involved in cancer growth or by harnessing the immune system to attack cancer cells. Hormone therapy blocks or removes hormones that fuel certain cancers. Each treatment option is tailored to the individual, depending on the cancer type, stage, and overall health. Advances continue to improve effectiveness and reduce side effects.

Track 2: Cancer Research

Cancer research focuses on understanding the complexities of cancer to develop effective treatments and preventive measures. It encompasses studying cancer biology, identifying genetic and environmental risk factors, and exploring new therapies. Researchers investigate how cancers grow, spread, and respond to various treatments, including targeted therapies and immunotherapies. Clinical trials play a crucial role in evaluating new treatments and improving existing ones. Advances in cancer research aim to enhance early detection, personalize treatment, and ultimately find cures. By continually expanding knowledge and innovation, cancer research strives to reduce the burden of cancer and improve patient outcomes globally.

Track 3: Types of Cancer

There are numerous types of cancer, each originating in different tissues or organs. The most common types include breast cancer, which develops in breast tissue, and lung cancer, often caused by smoking or environmental factors. Skin cancer, such as melanoma, arises from skin cells. Prostate cancer affects the male reproductive system, while colorectal cancer targets the colon or rectum. Liver, kidney, pancreatic, and stomach cancers affect various abdominal organs, while sarcomas originate in bones or connective tissues. Head and neck cancers develop in the throat, nose, or mouth. Leukemia and lymphoma are blood cancers affecting the immune system. Gynecologic cancers, including ovarian and cervical cancers, specifically affect women’s reproductive organs. Understanding these types helps guide diagnosis and treatment strategies.

Track 4: Cancer Prevention

Cancer prevention involves strategies to reduce the risk of developing cancer. Key measures include adopting a healthy lifestyle, such as maintaining a balanced diet, engaging in regular physical activity, and avoiding tobacco and excessive alcohol consumption. Vaccinations, like those against human papillomavirus (HPV) and hepatitis B, can protect against certain cancers. Regular screenings and early detection, such as mammograms and colonoscopies, help identify cancers at an early, more treatable stage. Additionally, protecting skin from excessive sun exposure and managing environmental and occupational risks are important. These proactive measures collectively contribute to reducing cancer incidence and improving overall health.

Track 5: Oncology

Oncology is a branch of medicine focused on the study, diagnosis, treatment, and prevention of cancer. There are various types of cancer, including breast cancer, skin cancer, and organ-specific cancers. Cancer biology examines the molecular and cellular changes that cause cancer, while cancer treatment encompasses surgery, chemotherapy, radiation, and immunotherapy. COVID-19 significantly impacted cancer care by delaying diagnosis and treatments. AI in cancer improves diagnosis, imaging, and treatment precision. Cancer epidemiology studies cancer patterns in populations. Pediatric and neuro-oncology address cancers in children and the brain, respectively. Imaging and biomarkers aid in early detection. Robotic oncology and radiation oncology are advancing treatment techniques. The cancer drug market continues to expand, with a focus on targeted therapies and new pharmacological developments.

Track 6: Breast Cancer

Recent advancements in breast cancer research have opened new horizons in treatment and understanding. Innovations like targeted therapies and immunotherapies are transforming treatment outcomes by attacking cancer cells more precisely and effectively. Additionally, advancements in early detection methods, such as liquid biopsies and imaging technologies, offer improved chances for early intervention and better prognoses. These developments signify a hopeful shift towards more personalized and effective treatments, aiming to enhance survival rates and quality of life for breast cancer patients.

Track 7: Radiation Therapy

Use of Radiation to kill diseased cells has become a standard diagnosis option for a wide range of malignancies. It utilizes X-rays, gamma rays, electron beams or protons to treat cancer. Radiotherapy can be used in three modalities: – Adjuvant radiotherapy, Palliative radiotherapy and Curative radiotherapy. Among all the available Anti-cancer therapies, Radiation therapy is the most conventional method for treating Cancers. Success depends on early diagnosis, the volume and histological nature of the Cancer. Techniques in Radiation therapy include Gamma Knife surgery, Medical dosimetry, Three-Dimensional Conformal Radiation Therapy, Triggered imaging radiosurgery, Brachytherapy, External Beam Radiation Therapy, Intensity Modulated Radiation Therapy, mage-Guided Radiotherapy, radioisotope therapy, Total Body Irradiation, Total Skin Irradiation and Stereotactic body radiation therapy.

Track 8: Cancer Case reports

Most cancers are a set of more than a hundred syndromes that expand all the way through time in any of the body’s materials. Each type of cancer has its particular capabilities; the simple procedures that produce most cancers are pretty comparable in all sorts of the diseases. A case record is the identified document of signs and symptoms, prognosis, remedies of the exceptional wounded of positive scientific records with unique therapeutic strategies. As about 7.6 million of latest instances of malignancy documented every year, half of them are from developing countries. Case reports will be up to date from all the statistics from the beyond.

Track 9: Neuro-Oncology

Neuro-oncology is a specialized field focused on the diagnosis and treatment of tumors in the brain, spinal cord, and nervous system. These cancers can be primary tumors, such as gliomas, meningiomas, and astrocytomas, which originate in the central nervous system, or metastatic tumors that spread from other parts of the body. Glioblastoma, an aggressive type of brain tumor, is among the most challenging to treat. Symptoms of neuro-oncological cancers can include headaches, seizures, cognitive changes, and neurological deficits, depending on the tumor's location. Treatment typically involves a combination of surgery, radiation therapy, and chemotherapy. Advances in immunotherapy, targeted therapies, and AI-guided imaging are offering new hope in improving patient outcomes, as neuro-oncology remains a critical area of research and innovation.

Track 10: Role of AI in Cancer

Artificial intelligence (AI) is revolutionizing cancer care by enhancing early detection, diagnosis, treatment planning, and research. AI algorithms, particularly in medical imaging, can quickly analyze scans such as MRIs or CTs, helping radiologists detect abnormalities with greater accuracy and speed. In pathology, AI can differentiate between cancerous and non-cancerous tissues more efficiently than traditional methods. Predictive models powered by AI assess a patient's cancer progression and treatment responses, allowing for personalized treatment plans. AI also aids in drug discovery, identifying potential new therapies faster by analyzing vast datasets. Furthermore, AI assists in managing clinical data, improving workflow, and minimizing human error. Overall, AI is transforming cancer care by making diagnosis and treatments more precise, efficient, and accessible.

Track 11: Cancer Personalized Medicine

Cancer personalized medicine tailors treatment to the individual characteristics of a patient’s cancer, based on their genetic makeup and the specific mutations driving the disease. This approach contrasts with one-size-fits-all treatments like chemotherapy. By analyzing the genetic profile of a tumor, doctors can identify targeted therapies, such as drugs that inhibit cancer-specific mutations, making treatments more effective and reducing side effects. Personalized medicine includes techniques like genomic testing, which guides treatment choices, and precision therapies, such as targeted therapies or immunotherapies. This approach is especially useful in cancers like breast, lung, and colorectal, where specific mutations can be identified and treated.

Track 12: Cancer Imaging

Cancer imaging is a critical tool in diagnosing, staging, and monitoring the progression of cancer. It involves various technologies that visualize tumors and abnormal tissues within the body. X-rays, including mammography, are commonly used for breast cancer detection. CT scans provide detailed cross-sectional images, while MRI offers high-resolution images of soft tissues, aiding in the detection of brain, spinal cord, and organ cancers. PET scans detect metabolic activity, highlighting areas of abnormal cell growth. Ultrasound is frequently used to evaluate tumors in organs like the liver or ovaries. Imaging is also crucial in guiding biopsies and tracking how well treatments, like chemotherapy or radiation, are working. Ongoing advancements in imaging technologies continue to improve early detection and treatment planning.

Track 13: Sarcoma

Sarcoma is a rare type of cancer that arises from connective tissues, including bones, muscles, fat, and cartilage. It is categorized into two main types: soft tissue sarcomas and bone sarcomas. Soft tissue sarcomas can occur in various locations, while bone sarcomas primarily affect the skeletal system. Symptoms may include swelling, pain, or lumps in affected areas, but they can be subtle and often overlooked. Diagnosis typically involves imaging tests and biopsy. Treatment options vary depending on the type and stage of sarcoma and may include surgery, radiation, and chemotherapy. Early detection is crucial for improving outcomes, as sarcomas can be aggressive and may metastasize. Ongoing research aims to enhance understanding and treatment of this complex cancer.

Track 14: Cancer Immunology & Immunotherapy

Cancer immunology is a division of immunology that studies deals between the immune system and cancer cells. It is an arena of exploration that aims to ascertain cancer immunotherapies to treat and delay progression of the infection. Immunotherapies can be characterized as active, passive or hybrid (active and passive). The immune response, comprising the recognition of cancer-specific antigens, methods the basis of targeted therapy (such as vaccines and antibody therapies) and tumour marker-based diagnostic tests.

Track 15: Cancer Diagnosis

Diagnostics plays an important role throughout Cancer treatment. Before treatment, to accurately locate Tumours, stage the disease, and determine an appropriate combination of cancer diagnosis. Diagnostics are used to track the size of the tumour, progression of the disease, and patient response to treatment, and modify your treatment accordingly. To confirm the diagnosis of most cancers, a liquid Biopsy needs is to be performed in which a tissue sample is removed from the tumour which occurred initially and studied under a microscope for detecting cancer cells. Endoscopy can be done by implanting a flexible plastic tube with a minute camera into body cavities or organs. Cancer Screening tests are used to detect the possibility of tumour cells which is present before symptoms occur. To identify cancer at its initial stage, different types of diagnostic tests are used to Screen at-risk individuals, Monitor treatment efficacy and disease progression or recurrence, Predict prognosis and direct treatment, Monitor an asymptomatic population for the early discovery of cancer, Earlier detection and treatment consequently drops cancer mortality, Diagnose a primary cancer and recognize the cancer subtype after whole cancer treatment, to display for any signs of metastasis or recurrence.

Track 16: Cancer Drugs

Cancer or its dealings can lower your resistance to infection and make you more likely to catch the other diseases. There are many diverse types of cancer drugs. Some medications can treat cancer and the others help to dismiss symptoms such as aching and sickness. The type of drugs you need to use for cure of your cancer depends on what type of cancer you have. Drug therapies work in various ways to extinguish cancer cells and discontinue them from diffusion or slow down their progress. Anticancer drugs or anticancer agents are used in Cancer. Drugs may also be used to decrease or relieve side effects of cancer and its treatment.

Track 17: Hematology- Oncology

Hematology- Oncology is the division of medicine associated to the study of diagnosis, treatment, and prevention of blood diseases and cancer. It includes such diseases as iron deficiency anemia, hemophilia, sickle cell disease, the thalassemia, leukemia and lymphoma. The study of hematology integrates clinical and laboratory medicine. Leukemia affects your white blood cells. These are major, infection-fighting part of your immune system, made in your bone marrow. The cancerous formation affecting the lymphocytes is called as lymphoma. Lymphocytes are one of the variabilities of white blood corpuscles. As part of Myeloma, the plasma is affected by the tumor cells. Blood cancers can cause many different symptoms. Some are mutual across all blood cancers, others are more distinctive of types of blood cancer. For example, lymphomas can be recognized by swollen lymph nodes and one of the most common symptoms of myeloma is bone pain, especially in the back.

Track 18: Cancer & Stem Cell Therapy

Stem-cell therapy is the use of stem cells to treat or avoid a disease or illness. Stem Cells and Tumours cancer cells also have the characteristic which is also associated with normal stems cells. Stem Cell Therapy is using to prevent the disease. Stems cells transplant is used to treatment of cancer like leukaemia, multiple myeloma & lymphoma. Cord Blood Stem and Cancer cord blood contains haematopoietic (blood) stem cell. They have long been used in stem cell treatments for leukaemia, blood and bone marrow disorders when chemotherapy is used.

Track 19: Head and Neck Cancer

Head and neck cancer encompasses a diverse group of malignancies that occur in the throat, mouth, nose, and surrounding areas. Common types include squamous cell carcinoma, often linked to tobacco and alcohol use, as well as human papillomavirus (HPV) infections. Symptoms can include persistent sore throat, difficulty swallowing, lumps, or changes in voice. Diagnosis typically involves imaging studies and biopsies. Treatment strategies may include surgery, radiation therapy, and chemotherapy, tailored to the cancer's type and stage. Early detection significantly improves prognosis, but many patients face challenges related to treatment side effects, including difficulties with speech and swallowing. Research continues to focus on better prevention, targeted therapies, and improving quality of life for survivors of head and neck cancer.

Track 20: Cancer Pharmacology

Cancer pharmacology plays an important role in medication development. In both the laboratory and the hospital, cancer pharmacology has had to adjust to the changing face of drug expansion by forming experimental representations and target orientated methods. It also emphases on developing new approaches to the clinical dealing of cancer over research that bridges the arenas of molecular carcinogenesis, biochemical pharmacology, radiation biology, and clinical pharmacology. It usually involves the pharmacological and oncological aspects of drugs at both.

Track 21: Cancer Epidemiology

Cancer epidemiology studies the patterns, causes, and effects of cancer within populations. It aims to identify risk factors, such as genetics, lifestyle, and environmental exposures, that contribute to cancer development. Researchers analyze incidence rates (new cancer cases), prevalence (total cases), and mortality (death rates) to understand trends in different demographic groups. Epidemiological studies help uncover connections between behaviors like smoking, diet, or UV exposure and cancer risk, enabling preventive measures. The field also tracks cancer disparities, revealing that certain populations have higher cancer rates due to factors like socio-economic status, access to healthcare, or geographic location. Insights from cancer epidemiology guide public health strategies, screening programs, and policies aimed at reducing cancer incidence and improving patient outcomes worldwide.

Track 22: Cancer Treatments

Cancer treatments vary based on the type, stage, and location of the cancer. The primary approaches include surgery, where the tumor is physically removed, and chemotherapy, which uses drugs to kill or slow the growth of cancer cells. Radiation therapy uses high-energy radiation to target cancerous cells, while immunotherapy boosts the body's immune system to fight cancer. Targeted therapies focus on specific molecules involved in cancer growth, offering precision treatment. Hormone therapy is used for cancers like breast and prostate that are influenced by hormones. Stem cell transplants help restore blood-forming stem cells after intensive treatments. Advances in precision medicine and AI are further personalizing treatment, improving effectiveness, and reducing side effects. Each method may be used alone or in combination.

Track 23: Organ Specific Cancer

Organ-specific cancers are malignancies that originate in specific organs of the body, each with distinct characteristics and treatment protocols. Common types include lung, breast, prostate, liver, and colorectal cancers. The development of these cancers can be influenced by genetic, environmental, and lifestyle factors, such as smoking, diet, and exposure to toxins. Symptoms vary widely depending on the organ affected and may include unexplained weight loss, pain, or changes in function. Diagnosis typically involves imaging techniques, blood tests, and biopsies. Treatment approaches often include surgery, radiation therapy, chemotherapy, and targeted therapies. Early detection is vital for improving outcomes, as many organ-specific cancers can progress quickly. Ongoing research aims to enhance prevention, early detection, and personalized treatment options.

Track 24: Cancer Biomarkers

Cancer biomarkers are molecules, genes, or proteins found in tissues, blood, or other body fluids that indicate the presence or progression of cancer. These biomarkers can be diagnostic, helping to detect cancer early, or prognostic, predicting the course of the disease. Predictive biomarkers guide treatment decisions by indicating how a patient might respond to specific therapies, such as targeted treatments or immunotherapies. Common biomarkers include HER2 in breast cancer, PSA in prostate cancer, and CA-125 for ovarian cancer. Advances in biomarker research are improving personalized medicine, allowing treatments to be tailored to an individual’s unique cancer profile. Additionally, cancer biomarkers aid in monitoring treatment efficacy and detecting recurrence, making them crucial tools in cancer management and therapy development.

Track 25: Skin Cancer

Skin cancer is the most common type of cancer, primarily caused by ultraviolet (UV) radiation from the sun or tanning beds. There are three major types: basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. BCC is the most common and least aggressive, often appearing as pearly or flesh-colored bumps. SCC is more aggressive than BCC, often manifesting as scaly, red patches. Melanoma is the most dangerous, originating in pigment-producing cells (melanocytes) and spreading quickly if not treated early. Risk factors include fair skin, excessive sun exposure, family history, and having numerous moles. Prevention includes using sunscreen, avoiding tanning beds, and regular skin checks. Early detection is key, and treatments include surgery, radiation, and topical therapies.

Track 26: Cancer: Lifestyle Connection and Nutrition

Many factors influence the development of cancer. Over the last 35 years, science has shown that physical activity, diet and body weight—especially being overheavy or obese is major risk influences for developing certain types of cancer. About a third of the most mutual cancers could be prohibited through lifestyle changes. The main interactive and environmental risk factors for cancer humanity in the world are related to diet use of addictive substances, sexual and generative health and contact to air pollution and use of polluted needles. The body’s capability to resist cancer may be facilitated by following a healthy diet, staying physically active, and avoiding excess body fat. Cancer and cancer treatments can also distress your body's ability to endure certain foods and use nutrients.

The recent advancements in the cancer treatments & cancer care are accelerating. A cluster of innovative treatments, often combined with other new or existing medicines, and frequently associated with biomarkers, are emerging from the research and development pipeline.

Over the past five years, 70 new oncology treatments have been launched and are being used to treat over 20 different tumour types.

The global cancer biomarker market size was valued at USD 10.3 billion in the year 2016 and is estimated to reach a value of USD 33.7 billion by 2025, growing with CAGR of 14.3 %. Growing prevalence of malignancies coupled with increasing focus on development of targeted therapies is a major factor affirming growth of this market.

Global cancer drugs market accounted for $78,238.9 million in 2015. The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of biosimilar. Global Oncology/Cancer Drugs Market is expected to garner $111.9 billion by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumour cell specific genes.

The global cancer diagnostics market is segmented based on technology, application, and region. This report studies the global cancer diagnostics market for the forecast period of 2015 to 2020. This market is expected to reach $13.1 Billion by 2020 from $7.1 Billion in 2015, and is poised to grow at a CAGR of 12.9% during the forecast period.

Importance and Scope

Radiation therapy is one of the prominent therapies used today in the treatment of cancer. Developed countries such as U.S., Europe have already considered radiotherapy procedure as the gold standard for cancer treatment. Radiotherapy refers to therapeutic procedures using high-energy electromagnetic waves or radioactive particulates to thwart abnormal cell growths and repair different physiological abnormalities within the human body. Euro Cancer 202 2 will be the best platform for radiologists, oncologists, researchers working in this field to connect and exchange ideas.

Related Companies/Industries:

Roche
Celgene Corporation
Johnson & Johnson
Pfizer Inc.
Bristol-Myers Squibb
Galenicum
Merck & Co., Inc.
AstraZeneca
AbbVie
Eli Lilly
Pangaea Oncology
Enia Lipotech
Ability Pharma
IDP Pharma
Pensa Pharma

Related Companies/Industries:

Society of Oncology and Cancer Research of Nigeria (SOCRON)
European society for medical oncology
American Society of Clinical Oncology
Swiss Group for Clinical Cancer Research
American Institute for Cancer Research (AICR)
National Foundation for Cancer Research
Cancer Research Institute
Institute of Cancer Research, London
European Academy of Tumour Immunology (EATI)
American Association for Cancer Research (AACR)
National Cancer Institute
Cancer Research UK
Memorial Sloan Kettering Cancer Centre
Ludwig Institute for Cancer Research
National Institutes of Health (NIH)
Breast Cancer Research Foundation
Amgen
University of Texas MD Anderson Cancer Centre
World Cancer Research Fund International
AstraZeneca

46th Euro-Global Summit on Cancer Therapy & Radiation Oncology gives you an opportunity to broaden your thinking and knowledge by listening to ideas and theories and recent developments in cancer. Euro Cancer 2024 conference can give you a wonderful opportunity to meet and interact with fellow researchers, experts across the World. It also allows you to meet new people.

Benefits of attending:

1. Learn from Top Professionals all over the world.
2. be familiar with the latest trends and challenges within your sector.
3. Share your research with top professors and get instant answers to your queries.
4. Participate in panel discussion session including live Q&A

Euro Cancer 2024, will be a truly international event; we expect to welcome healthcare professionals from over 100 countries. We also have global faculty who are leading experts in their fields. Gain valuable awareness from these prominent professionals from skilled institutions.

Benefits of Joining Conference:

Get your abstract published with DOI
Get Certified for your participation
Reduced Costs Affordability
Knock Down Geographical Barriers
Convenience from comfort of your own home or from work
They’re Archived: Ability to view events in the recording
Great resource for learning new career skillS
Learn from the Pros
Global exposure to your research
Make new connections
Significant time saving
Increased engagement
Wider Reach
More Engaging
Position yourself as the expert

Salient features

Keynote speeches and plenary talks by researchers all over the globe
Opportunity to meet globe expert’s in regenerative medical science
Posters, e-posters and video presentation by research community
International Certification by Organizing Committee
Publishing accepted abstracting International Journals
The study provides an in-depth analysis of the global Cardiology market

Target Audience

Cancer Researchers
Cancer Scientists
Cancer Investors
Cancer Societies
Directors of Laboratories
Universities
Industries
Investigators
Post-Doctoral Fellows
Research and Diagnostic Laboratories
Clinical Fellows
Medical Devices companies
Pharmaceutical Companies
Business Entrepreneurs.

Thanks to all our Speakers and conference attendees of Euro Cancer 2023 Conference

45^th Euro-Global Summit on Cancer Therapy & RadiationOncology during November 27-28, 2023 in Paris, France. The conference organized with a focus on “Exploring the Research Challenges & Advancements in Cancer and Therapeutic Strategies” was a great success where eminent keynote speakers from various reputed institutions with their magnificent presence addressed the gathering.

The conference was commenced with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Euro Cancer 2023, we would like to announce the commencement of the “46^th Euro-Global Summit on Cancer Therapy & Radiation Oncology” to be held during December 12-13, 2024 in Rome, Italy. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Oncology Research.

For more details: https://eurocancer.expertconferences.org/

Let us meet again @ Euro Cancer 2024

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	December 12-13, 2024
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View